Low AZT activity against HIV-2 infection

No evidence for cross resistance between nevirapine and d4T

Experimental compounds to target viral expression in latent cells

Case of MDR reinfection with MDR virus

Keystone HIV Pathogenesis and Vaccine Development Report 12-18 April 2004, Whistler, British Columbia, Canada

Keystone HIV Pathogenesis and Vaccine Report

A round-up of news about access to treatments, with links to sources

CD4 entry criteria dropped for UK tipranavir named patient access

Tenofovir/FTC co-formulation expected in US by September

Guidelines for T-20

Persistent HIV viraemia fosters immunologic harm and viral evolution

Latent drug-resistant HIV harboured for years

Non-prescription simvastatin in the UK: contraindicated with many HIV medications

Label changes for indinavir warn of several interactions including atazanavir and PDE5 inhibitors

Smoking during HIV infection may alter the natural history of HPV infection and increase the risk of cervical disease

Pharmacokinetic characteristics of ritonavir, zidovudine, lamivudine, and stavudine in children with HIV

Sexual transmission of HIV by acutely infected individuals has a disproportionate effect on the spread of HIV and may explain the current pandemic

Online medical resources

Conference abstracts

Treatment Access

Journal articles

Online publications

Volume 5 Number 6 July 2004 PDF

Volume 5 Number 5 June 2004

10th Anniversary Conference of the British HIV Association (BHIVA), 15–17 April 2004, Cardiff

BHIVA 2003-4 audit on HIV and pregnancy

More positive children are surviving into adult life and require tailored services

Other news from 10th BHIVA conference

Antiviral activity of foscarnet in salvage therapy

Kaletra therapy fails woman with subtype C virus with multiple mutations

Oral uridine to treat mitochondrial toxicity

Phase II results show ThGRF could be safe, effective treatment for lipodystrophy, says company

Reversibility of lipoatrophy in HIV patients 2 years after switching from a thymidine analogue to abacavir

Rapid clearance of HIV-1 is associated with decreased risk of AIDS

HIV patients get long-term boost with short, intermittent drug regimen

The 39th Annual Meeting of the European Association for the Study of the Liver (39th EASL)

Tenofovir blocks viral replication in HBV monoinfected and in HIV-HBV coinfected patients with lamivudine resistance

Compared to Caucasians, Africans have significantly higher rates of fibrosis and cirrhosis despite lower levels of HBV replication

Undetectable HIV viral load in HIV-HCV coinfected patients slows liver fibrosis progression rate

US government stops scientists attending International AIDS Conference

EMEA releases recommendations for better information for patients

Response to report from 11th CROI on treatment in primary infection

Conference abstracts

Treatment access

Journal articles

Online medical resources

Online publications

Volume 5 Number 5 June 2004 PDF

Volume 5 Number 4 May 2004

5th International Workshop on Clinical Pharmacology of HIV Therapy, 1-3 April 2004, Rome, Italy

Large reductions in plasma PK levels of saquinavir, amprenavir and lopinavir/r levels when given with tipranavir/ritonavir

Good generic drugs and good adherence in Rwanda

Steady state PK of nelfinavir and M8 in pregnancy

Higher nelfinavir concentrations improve response in children

PK of once daily lopinavir/r in children

2nd European HIV Drug Resistance Workshop, 11-13 March 2004, Rome, Italy

Understanding developments in HIV drug resistance for new drugs and targets — atazanavir, fusion (T-20) and receptor inhibitors

11th Conference on Retroviruses and Opportunistic Infections (CROI), 8-11 February 2004, San Francisco

HIV-associated dementia and cognitive dysfunction

Diabetes and HIV and HCV; aging/HIV and diabetes

Outcomes after two years of providing antiretrovirals in Khayelitsha, South Africa

A round-up of news on access to treatments

US treatment guidelines updated – March 2004

Atazanavir launched in UK

Tenofovir/FTC co-formulation application made to EMEA

Post navigation